These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23923282)

  • 21. Managing diabetic dyslipidemia: aggressive approach.
    Spratt KA
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S2-7. PubMed ID: 19451254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A constellation of complications: the metabolic syndrome.
    Grundy SM
    Clin Cornerstone; 2005; 7(2-3):36-45. PubMed ID: 16473259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome in the acute care setting.
    Selig PM
    AACN Clin Issues; 2006; 17(1):79-85. PubMed ID: 16462412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives.
    Salzano A; D'Assante R; Heaney LM; Monaco F; Rengo G; Valente P; Pasquali D; Bossone E; Gianfrilli D; Lenzi A; Cittadini A; Marra AM; Napoli R
    Endocrine; 2018 Aug; 61(2):194-203. PubMed ID: 29572708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronic hyperinsulinemia in insulin-resistant patients.
    Muntoni S; Muntoni S; Draznin B
    Curr Diab Rep; 2008 Jun; 8(3):233-8. PubMed ID: 18625122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men.
    Corona G; Bianchini S; Sforza A; Vignozzi L; Maggi M
    Hormones (Athens); 2015; 14(4):569-78. PubMed ID: 26732155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive summary: Standards of medical care in diabetes--2010.
    Diabetes Care; 2010 Jan; 33 Suppl 1(Suppl 1):S4-10. PubMed ID: 20042774
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical picture of metabolic syndrome. An update on this complex of conditions and risk factors.
    Doelle GC
    Postgrad Med; 2004 Jul; 116(1):30-2, 35-8. PubMed ID: 15274286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial dysfunction and the metabolic syndrome.
    McVeigh GE; Cohn JN
    Curr Diab Rep; 2003 Feb; 3(1):87-92. PubMed ID: 12643151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.
    Zhang J; Rocha NA; McCullough PA
    Rev Cardiovasc Med; 2018 Mar; 19(1):13-19. PubMed ID: 31032598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance in women's health: why it matters and how to identify it.
    Legro RS
    Curr Opin Obstet Gynecol; 2009 Aug; 21(4):301-5. PubMed ID: 19550327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
    Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
    Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes.
    Watts GF; Chan DC
    Atheroscler Suppl; 2010 Jun; 11(1):61-4. PubMed ID: 20452838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is this the worst outcome of metabolic syndrome? Hypophosphatemia and resulting cardiac arrest during the treatment of diabetic ketoacidosis with hypertriglyceridemia.
    Osuka A; Matsuoka T; Idoguchi K
    Intern Med; 2009; 48(16):1391-5. PubMed ID: 19687585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alimentary and lifestyle changes as a strategy in the prevention of metabolic syndrome and diabetes mellitus type 2: milestones and perspectives].
    M Hernández Ruiz de Eguilaz M; Batlle MA; Martínez de Morentin B; San-Cristóbal R; Pérez-Díez S; Navas-Carretero S; Martínez JA
    An Sist Sanit Navar; 2016; 39(2):269-89. PubMed ID: 27599954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.
    Ayyobi AF; Brunzell JD
    Am J Cardiol; 2003 Aug; 92(4A):27J-33J. PubMed ID: 12957324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.